4/A//SEC Filing
Duncan Gregory Scott 4/A
Accession 0001415889-23-002583
CIK 0001818844other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 12:54 PM ET
Size
5.8 KB
Accession
0001415889-23-002583
Insider Transaction Report
Form 4/AAmended
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2022-12-12+410,000→ 410,000 totalExercise: $0.28Exp: 2032-12-12→ Common Stock (410,000 underlying)
Footnotes (2)
- [F1]The reporting person filed a Form 4 on December 14, 2022 which incorrectly reported that on December 12, 2022 he was granted 480,000 Stock Options. This Form 4 amendment is being filed for the purpose of amending and restating the Form 4 to reflect that the reporting person was granted 410,000 Stock Options.
- [F2]The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001831127
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 12:54 PM ET
- Size
- 5.8 KB